---
title: 'CAR T-cells in autoimmunity: game changer or stepping stone?'
date: '2024-12-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39700499/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241220170923&v=2.18.0.post9+e462414
source: Blood
description: The advent of chimeric antigen receptor (CAR) T-cells has revolutionized
  the treatment landscape for hematologic malignancies, and emerging evidence suggests
  their potential in autoimmune diseases (AIDs). This article examines the early successes
  and future implications of B-cell-targeting CAR T-cell therapy in AIDs. Initial
  applications, particularly in refractory systemic lupus erythematosus (SLE), have
  demonstrated significant and durable clinical remissions, with accompanying evaluation
  ...
disable_comments: true
---
The advent of chimeric antigen receptor (CAR) T-cells has revolutionized the treatment landscape for hematologic malignancies, and emerging evidence suggests their potential in autoimmune diseases (AIDs). This article examines the early successes and future implications of B-cell-targeting CAR T-cell therapy in AIDs. Initial applications, particularly in refractory systemic lupus erythematosus (SLE), have demonstrated significant and durable clinical remissions, with accompanying evaluation ...